Daiki Sasabayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daiki Sasabayashi has a total of 416 co-authors. Here are the top co-authors by number of shared publications:
Michio Suzuki
Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
21 shared publicationsTsutomu Takahashi
14 shared publications- Tsutomu Takahashi
Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
14 shared publications Atsushi Furuichi
Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama city, Toyama 930-0194, Japan; Research Center for Idling Brain Science, University of Toyama, 2630 Sugitani, Toyama city, Toyama 930-0194, Japan
11 shared publicationsKyo Noguchi
Department of Radiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences , Toyama
11 shared publicationsYoichiro Takayanagi
Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences , Toyama
11 shared publications
Latest Publications
- 14 November 2026
- Published by Springer Nature in Brain Structure and Function
- Vol. 231 (9)
T1 contrast at the gray-white matter boundary during adolescence and its associations with cortical thickness and gyrification
- 14 November 2026
- Published by Springer Nature in Brain Structure and Function
- Vol. 231 (9)
T1 contrast at the gray-white matter boundary during adolescence and its associations with cortical thickness and gyrification
- 4 April 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (8) , 4716-4726
Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis
The Clinical High Risk (CHR) state for psychosis is consistently associated with widespread cortical thinning. However, the underlying mechanisms driving this neuroanatomical phenotype remain poorly understood. Here, we integrated the ENIGMA CHR Working Group's large pooled dataset (N = 1782 CHR, N = 1333 healthy controls) with an open-source PET molecular atlas to identify, for the first time, potential neurochemical drivers of cortical thinning associated with psychosis risk, transition, and its core symptoms. Using multilinear model analysis, we show that local chemoarchitecture significantly explains CT differences associated with CHR case-control status, the severity of negative symptoms, and future psychosis transition after excluding medication confounds. PET-based maps of dopamine, GABA, glutamate, serotonin, and norepinephrine consistently emerged as the strongest predictors of lower CT in CHR and psychosis transition (total dominance range: 62-69% and 58-87%, respectively), with contributions of monoamine systems being especially sensitive to medication exposure (8-23% change in dominance range). Negative symptom-associated cortical thinning was best explained by PET-based maps of dopamine, histamine, serotonin and opioid systems (total dominance range: 60-81%), with contributions of histamine being sensitive to medication exposure (9-19% change in dominance range). Combined, these results uniquely identify specific neurochemical systems - particularly monoaminergic, glutamatergic, and GABAergic pathways - as key molecular mechanisms associated with cortical thinning in people at high risk of developing psychosis.
- 4 April 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (8) , 4716-4726
Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis
The Clinical High Risk (CHR) state for psychosis is consistently associated with widespread cortical thinning. However, the underlying mechanisms driving this neuroanatomical phenotype remain poorly understood. Here, we integrated the ENIGMA CHR Working Group's large pooled dataset (N = 1782 CHR, N = 1333 healthy controls) with an open-source PET molecular atlas to identify, for the first time, potential neurochemical drivers of cortical thinning associated with psychosis risk, transition, and its core symptoms. Using multilinear model analysis, we show that local chemoarchitecture significantly explains CT differences associated with CHR case-control status, the severity of negative symptoms, and future psychosis transition after excluding medication confounds. PET-based maps of dopamine, GABA, glutamate, serotonin, and norepinephrine consistently emerged as the strongest predictors of lower CT in CHR and psychosis transition (total dominance range: 62-69% and 58-87%, respectively), with contributions of monoamine systems being especially sensitive to medication exposure (8-23% change in dominance range). Negative symptom-associated cortical thinning was best explained by PET-based maps of dopamine, histamine, serotonin and opioid systems (total dominance range: 60-81%), with contributions of histamine being sensitive to medication exposure (9-19% change in dominance range). Combined, these results uniquely identify specific neurochemical systems - particularly monoaminergic, glutamatergic, and GABAergic pathways - as key molecular mechanisms associated with cortical thinning in people at high risk of developing psychosis.
- Open Access
- 22 October 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (3) , 1707-1722
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
Brain network architecture is anticipated to influence future grey matter loss in individuals at Clinical High Risk (CHR) for psychosis. However, existing studies on grey matter structural network properties in CHR are scarce and constrained by small sample sizes. Here, we examined network topology differences comparing a) CHR versus healthy controls (HC); b) CHR who transitioned to psychosis (CHR-T) versus those who did not (CHR-NT); and c) different subsyndromes. We included structural scans from 1842 CHR individuals and 1417 HC individuals from 31 sites within the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. At the global level, CHR individuals exhibited lower structural covariance (q < 0.001; Cohen’s d = 0.164) and less optimal structural network configuration than HC (lower global efficiency and clustering coefficient, d = 0.100,0.087, qs <= 0.027). Though no global difference between CHR-T and CHR-NT, network distinctiveness of the frontal and temporal surface area networks was higher in CHR-T than CHR-NT (d = 0.223,0.237) and HC (d = 0.208,0.219) (qs < 0.001). Network distinctiveness of the frontal cortical thickness network was lower in CHR-T (d = 0.218, q < 0.001) than CHR-NT and HC (d = 0.165, q < 0.001). Importantly, higher network distinctiveness was associated with worse positive symptoms in CHR-NT (frontal surface area, q = 0.008, R2 = 0.013) and at trend with worse negative symptoms in CHR-T (frontal thickness, q = 0.063, R2 = 0.049). Further, the brief intermittent psychotic syndrome subgroup showed more severe network alterations. Together, brain structural networks inform symptoms and the risk of transition to psychosis in CHR individuals.
- 22 October 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (3) , 1707-1722
Open AccessStructural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
Brain network architecture is anticipated to influence future grey matter loss in individuals at Clinical High Risk (CHR) for psychosis. However, existing studies on grey matter structural network properties in CHR are scarce and constrained by small sample sizes. Here, we examined network topology differences comparing a) CHR versus healthy controls (HC); b) CHR who transitioned to psychosis (CHR-T) versus those who did not (CHR-NT); and c) different subsyndromes. We included structural scans from 1842 CHR individuals and 1417 HC individuals from 31 sites within the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. At the global level, CHR individuals exhibited lower structural covariance (q < 0.001; Cohen’s d = 0.164) and less optimal structural network configuration than HC (lower global efficiency and clustering coefficient, d = 0.100,0.087, qs <= 0.027). Though no global difference between CHR-T and CHR-NT, network distinctiveness of the frontal and temporal surface area networks was higher in CHR-T than CHR-NT (d = 0.223,0.237) and HC (d = 0.208,0.219) (qs < 0.001). Network distinctiveness of the frontal cortical thickness network was lower in CHR-T (d = 0.218, q < 0.001) than CHR-NT and HC (d = 0.165, q < 0.001). Importantly, higher network distinctiveness was associated with worse positive symptoms in CHR-NT (frontal surface area, q = 0.008, R2 = 0.013) and at trend with worse negative symptoms in CHR-T (frontal thickness, q = 0.063, R2 = 0.049). Further, the brief intermittent psychotic syndrome subgroup showed more severe network alterations. Together, brain structural networks inform symptoms and the risk of transition to psychosis in CHR individuals.
- 17 October 2025
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 52 (5)
Altered Cortical Gyrification Is Associated with Cortical and White Matter Microstructure in Individuals with Early Psychosis: A Multimodal Neuroimaging Study
Background and Hypothesis: Deviated brain folding patterns in psychosis may reflect dysfunctional brain development, more specifically cortical growth and white matter myelination. However, mechanisms that underlie the cortical folding disturbances and their relationship to clinical phenotypes in psychosis remain unknown. Study Design: This cross-sectional multimodal neuroimaging study combines structural and diffusion magnetic resonance imaging (MRI) in 203 individuals with early psychosis and 73 healthy individuals. The primary goal is to use local gyrification index (LGI), which quantifies cortical folding, to assess possible cortical abnormalities in subjects with early psychosis. The secondary goal is to combine gyrification measures with advanced diffusion MRI indices, namely, heterogeneity of fractional anisotropy (FA), a proxy for cortical cytoarchitecture, and free-water corrected FA, the latter associated with the tissue-related white matter microstructure. Finally, the relationship between these imaging measures with psychiatric symptoms and cognitive abilities are examined. Study Results: Compared to healthy individuals, the early psychosis group exhibited a significant LGI reduction, potentially reflecting sulcal widening and shallowing in the left temporo-parietal region. Local gyrification index was significantly associated with heterogeneity of FA in the corresponding region. Lower LGI was also associated with reduced FA in the white matter tracts connecting this region to the frontal lobe. Finally, lower LGI at the temporo-parietal junction was associated with more severe negative symptoms. Conclusions: We present the first in vivo evidence that anomalies in cortical folding may be linked to alterations in both the underlying cortical cytoarchitecture and associated microstructure of ipsilateral long-range white matter connections in psychosis.
- 17 October 2025
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 52 (5)
Altered Cortical Gyrification Is Associated with Cortical and White Matter Microstructure in Individuals with Early Psychosis: A Multimodal Neuroimaging Study
Background and Hypothesis: Deviated brain folding patterns in psychosis may reflect dysfunctional brain development, more specifically cortical growth and white matter myelination. However, mechanisms that underlie the cortical folding disturbances and their relationship to clinical phenotypes in psychosis remain unknown. Study Design: This cross-sectional multimodal neuroimaging study combines structural and diffusion magnetic resonance imaging (MRI) in 203 individuals with early psychosis and 73 healthy individuals. The primary goal is to use local gyrification index (LGI), which quantifies cortical folding, to assess possible cortical abnormalities in subjects with early psychosis. The secondary goal is to combine gyrification measures with advanced diffusion MRI indices, namely, heterogeneity of fractional anisotropy (FA), a proxy for cortical cytoarchitecture, and free-water corrected FA, the latter associated with the tissue-related white matter microstructure. Finally, the relationship between these imaging measures with psychiatric symptoms and cognitive abilities are examined. Study Results: Compared to healthy individuals, the early psychosis group exhibited a significant LGI reduction, potentially reflecting sulcal widening and shallowing in the left temporo-parietal region. Local gyrification index was significantly associated with heterogeneity of FA in the corresponding region. Lower LGI was also associated with reduced FA in the white matter tracts connecting this region to the frontal lobe. Finally, lower LGI at the temporo-parietal junction was associated with more severe negative symptoms. Conclusions: We present the first in vivo evidence that anomalies in cortical folding may be linked to alterations in both the underlying cortical cytoarchitecture and associated microstructure of ipsilateral long-range white matter connections in psychosis.
- Open Access
- 15 September 2025
- Published by Springer Nature in Research Square
Category-Specific Brain Structural Changes in Psychiatric Disorders and Conditions Using Well-Qualified Harmonization Dataset from Multiple Sites
Background Large-scale, multi-site brain magnetic resonance imaging (MRI) studies have revealed neuroanatomical alterations in various psychiatric disorders. However, site-specific differences—such as sampling and measurement biases—and the non-linear nature of brain features can limit individual-level investigations. These constraints underscore the need for a meta-analytic approach to accurately capture and compare brain structural changes across different psychiatric conditions. Methods Structural MRI data were collected from 1736 healthy controls and 1371 participants with clinical conditions, including major depressive disorder, schizophrenia, bipolar disorder, first-episode psychosis, ultra-high risk for psychosis, and autism spectrum disorder. A harmonization procedure was applied to reduce measurement bias across sites. Subsequently, deviations from normative trajectories—modeled on healthy controls—were estimated to diminish non-disease-related variations while preserving disease-specific patterns of brain changes. Results Significant reductions in cortical thickness, surface area, and subcortical volumes were observed in most clinical groups. The effect sizes exceeded those reported in previous meta-analyses, indicating enhanced sensitivity in detecting subtle neuroanatomical alterations. Furthermore, distinct profiles of brain alterations emerged across the examined psychiatric disorders and conditions, highlighting the heterogeneous nature of structural changes. Conclusion This study provides important insights into the neuroanatomical underpinnings of psychiatric disorders. By leveraging harmonized datasets and robust statistical methods, we demonstrate improved detection of structural alterations across psychiatric disorders, underscoring the value of multi-site collaborations and advanced analytic techniques for elucidating the complex neurobiology of psychiatric conditions.
- 15 September 2025
- Published by Springer Nature in Research Square
Open AccessCategory-Specific Brain Structural Changes in Psychiatric Disorders and Conditions Using Well-Qualified Harmonization Dataset from Multiple Sites
Background Large-scale, multi-site brain magnetic resonance imaging (MRI) studies have revealed neuroanatomical alterations in various psychiatric disorders. However, site-specific differences—such as sampling and measurement biases—and the non-linear nature of brain features can limit individual-level investigations. These constraints underscore the need for a meta-analytic approach to accurately capture and compare brain structural changes across different psychiatric conditions. Methods Structural MRI data were collected from 1736 healthy controls and 1371 participants with clinical conditions, including major depressive disorder, schizophrenia, bipolar disorder, first-episode psychosis, ultra-high risk for psychosis, and autism spectrum disorder. A harmonization procedure was applied to reduce measurement bias across sites. Subsequently, deviations from normative trajectories—modeled on healthy controls—were estimated to diminish non-disease-related variations while preserving disease-specific patterns of brain changes. Results Significant reductions in cortical thickness, surface area, and subcortical volumes were observed in most clinical groups. The effect sizes exceeded those reported in previous meta-analyses, indicating enhanced sensitivity in detecting subtle neuroanatomical alterations. Furthermore, distinct profiles of brain alterations emerged across the examined psychiatric disorders and conditions, highlighting the heterogeneous nature of structural changes. Conclusion This study provides important insights into the neuroanatomical underpinnings of psychiatric disorders. By leveraging harmonized datasets and robust statistical methods, we demonstrate improved detection of structural alterations across psychiatric disorders, underscoring the value of multi-site collaborations and advanced analytic techniques for elucidating the complex neurobiology of psychiatric conditions.
- 25 June 2025
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 52 (2)
Saturated Fatty Acids and White Matter Microstructure in Individuals With At-risk Mental State
Background and Hypothesis: Excessive saturated or deficient unsaturated fatty acids and white matter microstructural abnormalities are observed before the psychosis onset. Whereas fatty acids variations are implicated in white matter pathology, conventional Diffusion Tensor Imaging has limitations in disentangling their biological relevance. Free-water imaging provides improved biological specificity to white matter microstructure, such as fractional volume of free-water (FW) and tissue-specific fractional anisotropy (FAt). This study aims to investigate the associations between altered proportion of saturated or unsaturated fatty acids and free-water imaging parameters in prodromal psychosis. Study Design: We applied free-water imaging and Tract-Based Spatial Statistics to compare FAt and FW between 78 individuals with at-risk mental state (ARMS) and 129 healthy controls. In a subsample with available blood samples (n = 53 and n = 42, respectively), relationships between fatty acid composition of erythrocyte membrane and FAt or FW were examined alongside clinical and cognitive variables. Study Results: Compared to the controls, individuals with ARMS exhibited higher relative concentrations of saturated fatty acids as well as lower FAt and higher FW in multiple association and projection fibers. In the ARMS group, elevated proportion of saturated fatty acids was associated with lower FAt and with positive symptoms and impaired verbal fluency. Conclusions: The association of saturated fatty acids with FAt in ARMS suggests that fatty acids may influence disrupted white matter microstructure, such as impaired myelin maintenance prior to psychosis onset. Future studies should explore early interventions to mitigate white matter cellular deterioration by optimizing saturated fatty acid levels.
- 25 June 2025
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 52 (2)
Saturated Fatty Acids and White Matter Microstructure in Individuals With At-risk Mental State
Background and Hypothesis: Excessive saturated or deficient unsaturated fatty acids and white matter microstructural abnormalities are observed before the psychosis onset. Whereas fatty acids variations are implicated in white matter pathology, conventional Diffusion Tensor Imaging has limitations in disentangling their biological relevance. Free-water imaging provides improved biological specificity to white matter microstructure, such as fractional volume of free-water (FW) and tissue-specific fractional anisotropy (FAt). This study aims to investigate the associations between altered proportion of saturated or unsaturated fatty acids and free-water imaging parameters in prodromal psychosis. Study Design: We applied free-water imaging and Tract-Based Spatial Statistics to compare FAt and FW between 78 individuals with at-risk mental state (ARMS) and 129 healthy controls. In a subsample with available blood samples (n = 53 and n = 42, respectively), relationships between fatty acid composition of erythrocyte membrane and FAt or FW were examined alongside clinical and cognitive variables. Study Results: Compared to the controls, individuals with ARMS exhibited higher relative concentrations of saturated fatty acids as well as lower FAt and higher FW in multiple association and projection fibers. In the ARMS group, elevated proportion of saturated fatty acids was associated with lower FAt and with positive symptoms and impaired verbal fluency. Conclusions: The association of saturated fatty acids with FAt in ARMS suggests that fatty acids may influence disrupted white matter microstructure, such as impaired myelin maintenance prior to psychosis onset. Future studies should explore early interventions to mitigate white matter cellular deterioration by optimizing saturated fatty acid levels.
- Open Access
- 26 February 2025
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 45 (1) , e70010
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data‐Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders
One of the challenges in diagnosing psychiatric disorders is that the results of biological and neuroscience research are not reflected in the diagnostic criteria. Thus, data‐driven analyses incorporating biological and cross‐disease perspectives, regardless of the diagnostic category, have recently been proposed. A data‐driven clustering study based on subcortical volumes in 5604 subjects classified into four brain biotypes associated with cognitive/social functioning. Among the four brain biotypes identified in controls and patients with schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, and other psychiatric disorders, we further analyzed the brain biotype 1 subjects, those with an extremely small limbic region, for clinical utility. We found that the representative feature of brain biotype 1 is enlarged lateral ventricles. An enlarged ventricle, defined by an average z ‐score of left and right lateral ventricle volumes > 3, had a sensitivity of 99.1% and a specificity of 98.1% for discriminating brain biotype 1. However, the presence of an enlarged ventricle was not sufficient to classify patient subgroups, as 1% of the controls also had enlarged ventricles. Reclassification of patients with enlarged ventricles according to cognitive impairment resulted in a stratified subgroup that included patients with a high proportion of schizophrenia diagnoses, electroencephalography abnormalities, and rare pathological genetic copy number variations. Data‐driven clustering analysis of neuroimaging data revealed subgroups with enlarged ventricles and cognitive impairment. This subgroup could be a new diagnostic candidate for psychiatric disorders. This concept and strategy may be useful for identifying biologically defined psychiatric disorders in the future.
- 26 February 2025
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 45 (1) , e70010
Open AccessProposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data‐Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders
One of the challenges in diagnosing psychiatric disorders is that the results of biological and neuroscience research are not reflected in the diagnostic criteria. Thus, data‐driven analyses incorporating biological and cross‐disease perspectives, regardless of the diagnostic category, have recently been proposed. A data‐driven clustering study based on subcortical volumes in 5604 subjects classified into four brain biotypes associated with cognitive/social functioning. Among the four brain biotypes identified in controls and patients with schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, and other psychiatric disorders, we further analyzed the brain biotype 1 subjects, those with an extremely small limbic region, for clinical utility. We found that the representative feature of brain biotype 1 is enlarged lateral ventricles. An enlarged ventricle, defined by an average z ‐score of left and right lateral ventricle volumes > 3, had a sensitivity of 99.1% and a specificity of 98.1% for discriminating brain biotype 1. However, the presence of an enlarged ventricle was not sufficient to classify patient subgroups, as 1% of the controls also had enlarged ventricles. Reclassification of patients with enlarged ventricles according to cognitive impairment resulted in a stratified subgroup that included patients with a high proportion of schizophrenia diagnoses, electroencephalography abnormalities, and rare pathological genetic copy number variations. Data‐driven clustering analysis of neuroimaging data revealed subgroups with enlarged ventricles and cognitive impairment. This subgroup could be a new diagnostic candidate for psychiatric disorders. This concept and strategy may be useful for identifying biologically defined psychiatric disorders in the future.
- Open Access
- 22 November 2024
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 136, 111197
Increased structural covariance of cortical measures in individuals with an at-risk mental state
- 22 November 2024
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 136, 111197
Open AccessIncreased structural covariance of cortical measures in individuals with an at-risk mental state
- Open Access
- 9 February 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (5) , 1465-1477
Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
Machine learning approaches using structural magnetic resonance imaging (sMRI) can be informative for disease classification, although their ability to predict psychosis is largely unknown. We created a model with individuals at CHR who developed psychosis later (CHR-PS+) from healthy controls (HCs) that can differentiate each other. We also evaluated whether we could distinguish CHR-PS+ individuals from those who did not develop psychosis later (CHR-PS-) and those with uncertain follow-up status (CHR-UNK). T1-weighted structural brain MRI scans from 1165 individuals at CHR (CHR-PS+, n = 144; CHR-PS-, n = 793; and CHR-UNK, n = 228), and 1029 HCs, were obtained from 21 sites. We used ComBat to harmonize measures of subcortical volume, cortical thickness and surface area data and corrected for non-linear effects of age and sex using a general additive model. CHR-PS+ (n = 120) and HC (n = 799) data from 20 sites served as a training dataset, which we used to build a classifier. The remaining samples were used external validation datasets to evaluate classifier performance (test, independent confirmatory, and independent group [CHR-PS- and CHR-UNK] datasets). The accuracy of the classifier on the training and independent confirmatory datasets was 85% and 73% respectively. Regional cortical surface area measures-including those from the right superior frontal, right superior temporal, and bilateral insular cortices strongly contributed to classifying CHR-PS+ from HC. CHR-PS- and CHR-UNK individuals were more likely to be classified as HC compared to CHR-PS+ (classification rate to HC: CHR-PS+, 30%; CHR-PS-, 73%; CHR-UNK, 80%). We used multisite sMRI to train a classifier to predict psychosis onset in CHR individuals, and it showed promise predicting CHR-PS+ in an independent sample. The results suggest that when considering adolescent brain development, baseline MRI scans for CHR individuals may be helpful to identify their prognosis. Future prospective studies are required about whether the classifier could be actually helpful in the clinical settings.
- 9 February 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (5) , 1465-1477
Open AccessUsing brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
Machine learning approaches using structural magnetic resonance imaging (sMRI) can be informative for disease classification, although their ability to predict psychosis is largely unknown. We created a model with individuals at CHR who developed psychosis later (CHR-PS+) from healthy controls (HCs) that can differentiate each other. We also evaluated whether we could distinguish CHR-PS+ individuals from those who did not develop psychosis later (CHR-PS-) and those with uncertain follow-up status (CHR-UNK). T1-weighted structural brain MRI scans from 1165 individuals at CHR (CHR-PS+, n = 144; CHR-PS-, n = 793; and CHR-UNK, n = 228), and 1029 HCs, were obtained from 21 sites. We used ComBat to harmonize measures of subcortical volume, cortical thickness and surface area data and corrected for non-linear effects of age and sex using a general additive model. CHR-PS+ (n = 120) and HC (n = 799) data from 20 sites served as a training dataset, which we used to build a classifier. The remaining samples were used external validation datasets to evaluate classifier performance (test, independent confirmatory, and independent group [CHR-PS- and CHR-UNK] datasets). The accuracy of the classifier on the training and independent confirmatory datasets was 85% and 73% respectively. Regional cortical surface area measures-including those from the right superior frontal, right superior temporal, and bilateral insular cortices strongly contributed to classifying CHR-PS+ from HC. CHR-PS- and CHR-UNK individuals were more likely to be classified as HC compared to CHR-PS+ (classification rate to HC: CHR-PS+, 30%; CHR-PS-, 73%; CHR-UNK, 80%). We used multisite sMRI to train a classifier to predict psychosis onset in CHR individuals, and it showed promise predicting CHR-PS+ in an independent sample. The results suggest that when considering adolescent brain development, baseline MRI scans for CHR individuals may be helpful to identify their prognosis. Future prospective studies are required about whether the classifier could be actually helpful in the clinical settings.
- 23 January 2024
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (2)
The relationship between gray/white matter contrast and cognitive performance in first-episode schizophrenia
Previous postmortem brain studies have revealed disturbed myelination in the intracortical regions in patients with schizophrenia, possibly reflecting anomalous brain maturational processes. However, it currently remains unclear whether this anomalous myelination is already present in early illness stages and/or progresses during the course of the illness. In this magnetic resonance imaging study, we examined gray/white matter contrast (GWC) as a potential marker of intracortical myelination in 63 first-episode schizophrenia (FESz) patients and 77 healthy controls (HC). Furthermore, we investigated the relationships between GWC findings and clinical/cognitive variables in FESz patients. GWC in the bilateral temporal, parietal, occipital, and insular regions was significantly higher in FESz patients than in HC, which was partly associated with the durations of illness and medication, the onset age, and lower executive and verbal learning performances. Because higher GWC implicates lower myelin in the deeper layers of the cortex, these results suggest that schizophrenia patients have less intracortical myelin at the time of their first psychotic episode, which underlies lower cognitive performance in early illness stages.
- 23 January 2024
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (2)
The relationship between gray/white matter contrast and cognitive performance in first-episode schizophrenia
Previous postmortem brain studies have revealed disturbed myelination in the intracortical regions in patients with schizophrenia, possibly reflecting anomalous brain maturational processes. However, it currently remains unclear whether this anomalous myelination is already present in early illness stages and/or progresses during the course of the illness. In this magnetic resonance imaging study, we examined gray/white matter contrast (GWC) as a potential marker of intracortical myelination in 63 first-episode schizophrenia (FESz) patients and 77 healthy controls (HC). Furthermore, we investigated the relationships between GWC findings and clinical/cognitive variables in FESz patients. GWC in the bilateral temporal, parietal, occipital, and insular regions was significantly higher in FESz patients than in HC, which was partly associated with the durations of illness and medication, the onset age, and lower executive and verbal learning performances. Because higher GWC implicates lower myelin in the deeper layers of the cortex, these results suggest that schizophrenia patients have less intracortical myelin at the time of their first psychotic episode, which underlies lower cognitive performance in early illness stages.